Investigational Site Number :0360004

Hobart, Tasmania 7001

0 studies enrolling now · 1 studies all time

What they study most

Non-relapsing Secondary Progressive Multiple Sclerosis

Studies at this site

• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed